WELLS FARGO & COMPANY/MN - CELLULAR BIOMEDICINE GROUP I ownership

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of CELLULAR BIOMEDICINE GROUP I
ValueSharesWeighting
Q4 2020$461,000
+92.9%
25,093
+93.3%
0.00%
Q3 2020$239,000
+5.3%
12,980
-14.4%
0.00%
Q2 2020$227,000
+56.6%
15,160
+65.8%
0.00%
Q1 2020$145,000
-7.6%
9,143
-5.7%
0.00%
Q4 2019$157,000
+8.3%
9,694
-0.9%
0.00%
Q3 2019$145,000
-8.8%
9,780
+1.7%
0.00%
Q2 2019$159,000
-12.2%
9,621
-7.9%
0.00%
Q1 2019$181,000
+81.0%
10,451
+84.6%
0.00%
Q4 2018$100,000
-69.3%
5,662
-68.4%
0.00%
Q3 2018$326,000
+20.3%
17,946
+29.7%
0.00%
Q2 2018$271,000
+613.2%
13,832
+283.2%
0.00%
Q3 2017$38,000
-63.5%
3,610
-58.9%
0.00%
Q1 2017$104,000
-9.6%
8,7790.0%0.00%
Q4 2016$115,000
+66.7%
8,779
+83.5%
0.00%
Q3 2016$69,000
+21.1%
4,7850.0%0.00%
Q2 2016$57,000
-46.7%
4,785
-16.5%
0.00%
Q1 2016$107,000
+2.9%
5,730
+18.3%
0.00%
Q4 2015$104,000
+22.4%
4,843
-3.6%
0.00%
Q3 2015$85,000
+372.2%
5,025
+919.3%
0.00%
Q2 2015$18,000
+800.0%
493
+473.3%
0.00%
Q1 2015$2,000860.00%
Other shareholders
CELLULAR BIOMEDICINE GROUP I shareholders Q1 2021
NameSharesValueWeighting ↓
S. MUOIO & CO. LLC 40,000$734,0000.83%
WATER ISLAND CAPITAL LLC 133,286$2,444,0000.21%
Walleye Capital LLC 90,666$1,663,0000.18%
GLAZER CAPITAL, LLC 202,158$3,708,0000.18%
First Trust Capital Management L.P. 35,613$653,0000.18%
EQUITEC PROPRIETARY MARKETS, LLC 12,500$229,0000.18%
EQUITEC PROPRIETARY MARKETS, LLC 10,600$194,0000.15%
Olympiad Research LP 13,484$247,0000.13%
Yakira Capital Management, Inc. 17,588$323,0000.10%
Alpine Global Management, LLC 25,000$459,0000.10%
View complete list of CELLULAR BIOMEDICINE GROUP I shareholders